- Home
- ARQT vs SFNC Comparison
ARQT vs SFNC Comparison
Compare ARQT & SFNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | SFNC |
|---|---|---|
| Founded | 2016 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ARQT | SFNC |
|---|---|---|
| Price | $24.14 | $22.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $37.00 | $25.93 |
| AVG Volume (30 Days) | ★ 2.4M | 1.2M |
| Earning Date | 10-27-2026 | 10-15-2026 |
| Dividend Yield | N/A | ★ 3.84% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | 0.03 | ★ 0.93 |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $42.98 | $11.04 |
| Revenue Next Year | $27.75 | $4.50 |
| P/E Ratio | $816.33 | ★ $24.06 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $19.30 | $17.00 |
| 52 Week High | $31.77 | $24.32 |
Technical Indicators
Market Signals| Indicator | ARQT | SFNC |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 43.66 |
| Support Level | $22.82 | $22.22 |
| Resistance Level | $24.67 | $22.62 |
| Average True Range (ATR) | 1.27 | 0.45 |
| MACD | -0.25 | -0.04 |
| Stochastic Oscillator | 15.55 | 30.94 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.